Metabolic Syndrome and Myocardial Involvement in HIV-Infected Patients

1. Gorin I, Leibowitch M, et al. AIDS in a Haitian woman with cardiac Kaposi’s sarcoma and Whipple’s disease. Lancet 1983;i:7678. The first clinical description of cardiovascular disease complicating HIV infection.Search in Google Scholar

2. Calza L, Manfredi R, Farneti B, Chiodo F. Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy. Int J Antimicrob Agents. 2003.10.1016/S0924-8579(03)00100-6Search in Google Scholar

3. Giuseppe Barbaro, Barbarini Giorgio Human immunodeficiency virus & cardiovascular risk. Indian J Med Res 134, December 2011, pp 898-903.10.4103/0971-5916.92634Search in Google Scholar

4. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS. 2003;17:S141S148.10.1097/00002030-200304001-00017Open DOISearch in Google Scholar

5. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Therapeut. 2006; 13: 248-60.10.1097/01.mjt.0000162013.66614.16Search in Google Scholar

6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506.10.1210/jc.2006-219017456578Open DOISearch in Google Scholar

7. Carr A, Cooper D. Adverse effects of antiretroviral therapy. Lancet. 2000; 356: 1423-3010.1016/S0140-6736(00)02854-3Search in Google Scholar

8. Rudich A, Ben-Romano R, Etzion S, Bashan N. Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors. Acta Physiol Scand 2005; 183:75.10.1111/j.1365-201X.2004.01383.xSearch in Google Scholar

9. Kim RJ, Wilson CG, Wabitsch M, Lazar MA, teppan CM. HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism. Obesity 2006;14:994e1002 (SilverSpring).10.1038/oby.2006.114Open DOISearch in Google Scholar

10. Andersen O, Haugaard SB, Andersen UB, Friis-Moller N, Storgaard H, Volund A, et al. Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function. Metabolism 2003;52:1343e53.1456468810.1016/S0026-0495(03)00201-4Search in Google Scholar

11. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003; 33:506.10.1097/00126334-200308010-0001212869840Search in Google Scholar

12. Worm SW, Sabin C, Weber R et, ak, Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major classes: the data collection on adverse events of anti-HIV drugs (DAD) study. J Infect Dis 2010; 20 : 318-30.10.1086/649897Search in Google Scholar

13. Andrew Carr; Katherine Samaras; Samantha Burton; Matthew Law; Judith Freund; Donald Chisholm; David Cooper; A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors, may 1998.Search in Google Scholar

14. Antoine Biron, Christine Bobin-Dubigeon, Christelle Volteau, Metabolic Syndrome in French HIV-Infected Patients: Prevalence and Predictive Factors After 3 Years of Antiretroviral Therapy 21 Nov 2012.Search in Google Scholar

15. Parisa Kalantari, Omid F. Harandi, Pamela A. Hankey HIV-1 Tat Mediates Degradation of RON Receptor Tyrosine Kinase, a Regulator of Inflammation, July 15, 2008.10.4049/jimmunol.181.2.1548Search in Google Scholar

16. Bastard JP, Maachi M, Lagathu C, Recent advances in the relationship between obesity, inflammation, and insulin resistance, 2006.Search in Google Scholar

17. Karine Clément, Nathalie Viguerie, Christine Poitou, Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects, 1 Nov 2004.10.1096/fj.04-2204comSearch in Google Scholar

18. Harold S.Sacks, John N.Fains, Human epicardial adipose tissue: A review, 2007.Search in Google Scholar

19. Ngatchou W, Lemogoum D, Ndobo P, Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon 4 January 2013.10.2147/VHRM.S42350Search in Google Scholar

20. Davide Gibellini, Pier Luigi Tazzari, Francesca Ricci, Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells, 17 November 2011.10.1002/jcb.23446Search in Google Scholar

21. Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepción ML, HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy, 2006.10.1177/135965350601100610Search in Google Scholar

22. Frank Palella;Rose Baker;Anne Moorman;Joan Chmiel;Kathleen Wood;John Brooks;Scott Holmberg; Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study 2006/09/01.10.1097/01.qai.0000233310.90484.16Search in Google Scholar

23. Nina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, Conventional cardiovascular risk factors in HIV infection: how conventional are they?”, Caroline Sabin; Signe Worm; 2008/05/01” Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study 1 oct 2010.Search in Google Scholar

24. Clay Bavinger, Eran Bendavid, Katherine Niehaus Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review 26 March 2013.10.1371/journal.pone.0059551Search in Google Scholar

25. Pacheco AGFGB, Fonseca MDJ, Moreira RI: Carotid intima-media thickness (cIMT) in HIV-infected patients in Rio de Janeiro, Brazil: Overall and gender analysis 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2013, Kuala Lumpur; Birmingham, AL, USA.Search in Google Scholar

26. Kenneth A. Lichtenstein, Carl Armon, Kate Buchacz Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients the HOPS Investigators, 2013.10.5888/pcd10.120083Search in Google Scholar

27. Lewis W. AIDS: cardiac findings from 115 autopsies. Prog Cardiovasc Dis 1989; 32:207.10.1016/0033-0620(89)90026-1Search in Google Scholar

28. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998; 14:1071.10.1089/aid.1998.14.10719718123Search in Google Scholar

29. Remick J, Georgiopoulou V, Marti C, et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation 2014; 129:1781.10.1161/CIRCULATIONAHA.113.004574400634324778120Search in Google Scholar

30. Barbaro G, Iacobellis G. Metabolic syndrome associated with HIV and highly active antiretroviral therapy. Curr Diab Rep 2009; 9 : 37-42.10.1007/s11892-009-0008-719192423Search in Google Scholar

31. Mondy KE, Gottdiener J, Overton ET, et al. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis 2011; 52:378.10.1093/cid/ciq06621217185Open DOISearch in Google Scholar

32.. Cerrato E, D’Ascenzo F, Biondi-Zoccai G, et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J 2013; 34:1432.10.1093/eurheartj/ehs4712333560323335603Open DOISearch in Google Scholar

33. Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013; 128:814.10.1161/CIRCULATIONAHA.113.00171923817574Search in Google Scholar

34. Ntusi N, O’Dwyer E, Dorrell L, et al. HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema. Circ Cardiovasc Imaging 2016; 9:e004430.10.1161/CIRCIMAGING.115.00443026951605Search in Google Scholar

35. Lipshultz SE, Easley KA, Orav EJ, et al. Cardiac dysfunction and mortality in HIV-infected children. The prospective P2C2 HIV multicenter study Circulation 2000;102:15428.10.1161/01.CIR.102.13.1542Search in Google Scholar

36. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998; 339:1093.10.1056/NEJM1998101533916019770555Search in Google Scholar

37. John Gill et. al-Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996-2006: Collaborative Analysis of 13 HIV Cohort Studies Clin Infect Dis. Author manuscript; available in PMC 2011 August 18.Search in Google Scholar

38. “ Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects” Adelzon A Paula, Melissa CN Falcão and Antonio G Pacheco, 2013Search in Google Scholar